Tiago Reis Marques's most recent trade in Pasithea Therapeutics Corp was a trade of 960 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on May 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 12 May 2025 | 960 | 40,001 | - | 0.8 | 792 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 11,669 | 11,669 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 11,669 | 11,669 | - | - | Stock Option (right to buy) | |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 23 Nov 2022 | 5,000 | 815,000 | - | 1 | 5,000 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.03 per share. | 23 Nov 2022 | 2,000 | 819,206 | - | 1.0 | 2,060 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.02 per share. | 23 Nov 2022 | 1,206 | 817,206 | - | 1.0 | 1,230 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.03 per share. | 23 Nov 2022 | 1,000 | 816,000 | - | 1.0 | 1,030 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.07 per share. | 21 Oct 2022 | 4,400 | 810,000 | - | 1.1 | 4,708 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.08 per share. | 21 Oct 2022 | 600 | 805,600 | - | 1.1 | 648 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 23 Jun 2022 | 2,900 | 802,900 | - | 1.0 | 2,880 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 23 Jun 2022 | 1,800 | 805,000 | - | 1.0 | 1,789 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 23 Jun 2022 | 200 | 803,100 | - | 1.0 | 196 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 23 Jun 2022 | 100 | 803,200 | - | 1.0 | 99 | Common Stock |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 200,000 | 800,000 | - | 0 | Common Stock | |
Pasithea Therapeutics Corp | Tiago Reis Marques | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 200,000 | 200,000 | - | - | Stock Option (to acquire Common Stock) |